Skip to main content

Health Care

House Democrats are committed to expanding access to quality, affordable health care coverage, strengthening protections for people with pre-existing conditions, and lowering prescription drug prices and the cost of health care overall.

House Democrats are committed to expanding access to quality, affordable health care coverage, strengthening protections for people with pre-existing conditions, and lowering prescription drug prices and the cost of health care overall.
 
Under President Biden and Congressional Democrats, the uninsured rate is at an all-time low. While Republicans vote against legislation to lower health care costs, House Democrats are working to bring down the overall costs of health care and increase access to health care coverage.
 
With the landmark Inflation Reduction Act, House Democrats took direct action to reduce health care costs for millions of Americans. For the first time, Medicare will be able to negotiate prescription drug prices for high-cost drugs. The law also caps out-of-pocket prescription drug costs for Medicare recipients at $2,000 annually and establishes a $35 cap for a month’s supply of insulin. The Inflation Reduction Act also protects progress made under President Biden to expand access to quality, affordable health care coverage by continuing the expanded premium tax credits originally passed in the American Rescue Plan, which lowered health care premiums for millions of working families.
 
This built upon the Affordable Care Act – enacted by President Obama and Congressional Democrats in 2010 – that has put American families in control of their own health care and ended a system that put profits ahead of patients. Since its enactment, 35 million Americans have gained access to quality, affordable health coverage. Americans with pre-existing conditions can no longer be discriminated against by insurance companies. Parents can now keep their children on their insurance plans up to age twenty-six. Insurance companies are no longer allowed to put annual or lifetime limits on coverage or drop people when they get sick. Additionally, thanks to the law, Medicare costs – from premiums and deductibles to overall program spending – have slowed to well below the levels projected before the law passed.
 
These reforms were crucial, especially when the COVID-19 pandemic struck but more action was needed.  That’s why House Democrats worked to enact legislation right away - without any Republican support - to ensure that testing, treatment, and vaccinations for COVID-19 would be covered with no out-of-pocket costs to Americans.

House Democrats remain committed to the goal of affordable, accessible health care for all.  


Related

On yet another issue – this time the extension of the children’s health insurance program – it seems that President Bush is obstinately determined to defy the will of the American people and to veto carefully crafted, responsible legislation that is supported by bipartisan majorities of the House and Senate and the state’s governors.
Democrats work to extend and expand the State Children's Health Insurance Program.
After seven months in office, House Democrats are addressing the priorities of the American people. We have passed significant legislation with bipartisan support, and we are making real progress on important issues in order to defend our country, restore the American dream, and achieve energy independence.
On Wednesday, the House passed legislation reauthorizing the State Children's Health Insurance Program and protecting Medicare for America's seniors.
The 110th Congress is making progress on the American people’s priorities, despite intense opposition from President Bush and Rubberstamp Republicans on many issues.
This week, the House finished work on three appropriations bills that invest in America's priorities after years of Republicans actually decreasing investments in those priorities.
Yesterday, the House passed a stem cell bill that will allow lifesaving stem cell research to continue.
The House passes the Stem Cell Research Enhancement Act